Related references
Note: Only part of the references are listed.Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome
Masafumi Kobayashi et al.
MODERN RHEUMATOLOGY (2011)
Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease Clinical Features and Long-Term Outcome: A Case-Control Study of 8 Patients
Arnaud Hot et al.
MEDICINE (2010)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases
S. Fukaya et al.
RHEUMATOLOGY (2008)
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France
T. Lequerre et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Etanercept for therapy-resistant macrophage activation syndrome
Balahan Makay et al.
PEDIATRIC BLOOD & CANCER (2008)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature
J.-B. Arlet et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Macrophage activation syndrome in juvenile idiopathic arthritis
Elisabetta Cortis et al.
ACTA PAEDIATRICA (2006)
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis - Results from the British Society for Rheumatology Biologics Register
Kimme L. Hyrich et al.
ARTHRITIS AND RHEUMATISM (2006)
Diagnosis and management of adult onset Still's disease
P Efthimiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis - Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Prolonged remission in adult-onset Still's disease with etanercept
R Kumari et al.
CLINICAL RHEUMATOLOGY (2006)
Rapid responses to anakinra in patients with refractory adult-onset Still's disease
AA Fitzgerald et al.
ARTHRITIS AND RHEUMATISM (2005)
Tumour necrosis factor a blocking agents in refractory adult Still's disease: an observational study of 20 cases
B Fautrel et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients
A Kokkinos et al.
CLINICAL RHEUMATOLOGY (2004)
Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab
A Aouba et al.
RHEUMATOLOGY (2003)
Humanized monoclonal anti-interieukin-6 receptor antibody for treatment of intractable adult-onset Still's disease
M Iwamoto et al.
ARTHRITIS AND RHEUMATISM (2002)
Etanercept in the treatment of adult patients with Still's disease
ME Husni et al.
ARTHRITIS AND RHEUMATISM (2002)
Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy
A Stern et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2001)
Share Paper
